RecruitingPhase 4NCT07732010

TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED)

A Single Center Investigator Initiated Trial Using TRYPTYR as a Treatment for Patients With Dry Eye Disease

Sponsor

NYU Langone Health

Enrollment

50 participants

Start Date

Jul 6, 2026

Study Type

INTERVENTIONAL

Conditions

Dry Eye Disease (DED)

Summary

The purpose of this research study is to determine the effectiveness of TRYPTYR as a treatment for Dry Eye Disease. The primary efficacy variable is change from baseline in the Ocular Surface Disease Index (OSDI) at week 2. The co-primary efficacy variables are change from baseline in the National Eye Institute (NEI) scale of the cornea and NEI scale of the conjunctiva at 1 month (the third visit).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called TRYPTYR (Acoltremon ophthalmic solution 0.003%) for people with dry eye disease (ded). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.